A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Respivert Ltd
ClinicalTrials.gov Identifier:
NCT01661244
First received: August 7, 2012
Last updated: March 1, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)